Literature DB >> 7119411

Subacute hepatic failure; is it a distinct entity?

B N Tandon, Y K Joshi, L Krishnamurthy, H D Tandon.   

Abstract

We prospectively studied patients with subacute hepatic failure due to subacute hepatitis to find out 1) its relative prevalence compared to acute liver failure due to fulminant hepatitis and chronic liver failure due to chronic active hepatitis; 2) its clinical, biochemical, and morphological hepatitis; 3) the role of virus B in its etiology; and 4) its prognosis and whether there were any predictors of bad prognosis. Thirty-three patients with subacute hepatic failure were registered during a 3-year period. Persistent or progressively deepening jaundice of 8 weeks duration and development of moderate to sever ascites in patients starting otherwise typical features of acute viral hepatitis, defined the subacute hepatic failure group. The characteristic features included moderate to deep icterus, ascites, and peripheral edema; encephalopathy and gastrointestinal bleeding were infrequent. Liver function tests were abnormal but not diagnostic. Submassive and bridging necrosis of the liver were the main histological findings. Virus B etiology was recorded in 42% of the patients. Mortality was 66%. This condition is highly fatal and not infrequent in India.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7119411     DOI: 10.1097/00004836-198208000-00010

Source DB:  PubMed          Journal:  J Clin Gastroenterol        ISSN: 0192-0790            Impact factor:   3.062


  8 in total

Review 1.  Approach to clinical syndrome of jaundice and encephalopathy in tropics.

Authors:  Anil C Anand; Hitendra K Garg
Journal:  J Clin Exp Hepatol       Date:  2014-06-06

2.  Liver histology as predictor of outcome in patients with acute-on-chronic liver failure (ACLF).

Authors:  Archana Rastogi; Ashish Kumar; Puja Sakhuja; Chhagan Bihari; Ranjana Gondal; Syed Hissar; Hitendra Garg; Shiv Kumar Sarin
Journal:  Virchows Arch       Date:  2011-07-09       Impact factor: 4.064

Review 3.  Acute and acute severe (fulminant) autoimmune hepatitis.

Authors:  Albert J Czaja
Journal:  Dig Dis Sci       Date:  2012-10-23       Impact factor: 3.199

4.  Treatment of fulminant viral hepatic failure with prostaglandin E. A preliminary report.

Authors:  S B Sinclair; G A Levy
Journal:  Dig Dis Sci       Date:  1991-06       Impact factor: 3.199

5.  Hepatitis virus non-A, non-B: the cause of a major public health problem in India.

Authors:  B N Tandon; B M Gandhi; Y K Joshi; M Irshad; H Gupta
Journal:  Bull World Health Organ       Date:  1985       Impact factor: 9.408

Review 6.  Epidemiology of hepatitis B virus infection in India.

Authors:  B N Tandon; S K Acharya; A Tandon
Journal:  Gut       Date:  1996       Impact factor: 23.059

7.  Biochemical and clinical response of fulminant viral hepatitis to administration of prostaglandin E. A preliminary report.

Authors:  S B Sinclair; P D Greig; L M Blendis; M Abecassis; E A Roberts; M J Phillips; R Cameron; G A Levy
Journal:  J Clin Invest       Date:  1989-10       Impact factor: 14.808

Review 8.  Acute liver failure in Japan: definition, classification, and prediction of the outcome.

Authors:  Kayoko Sugawara; Nobuaki Nakayama; Satoshi Mochida
Journal:  J Gastroenterol       Date:  2012-07-24       Impact factor: 7.527

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.